Ann Arbor, MI., February 2007 As lifestyles change, so do the needs and demands for solutions to new health conditions. Factors such as increased air travel, lack of exercise, improper diets, growing obesity and aging are causing more Americans to encounter vascular problems. Leg cramps, spider veins, varicose veins, hemorrhoids, intermittent claudication and other circulatory issues are becoming more and more common, not helped by standing for long periods, or sitting at a computer for hours on end.
While spider veins can be unsightly, they are not painful, unlike varicose veins and hemorrhoids. Vein problems, in particular varicose veins, affect one in two people over 50 years of age. While people are prepared to discuss vein problems, they are much less likely to discuss hemorrhoids. They are embarrassed to talk about hemorrhoids, which often keeps them from seeking treatment, and adds to their discomfort. But this condition, which affects one-third of the population, needs to be addressed. While severe varicose veins can be surgically treated, a painful procedure in itself, less severe veins and spider veins, as well as hemorrhoids, can be relieved with alternative medicine.
DiosVeinTM, a brand of diosmin has recently been launched into the U.S. supplement and nutraceutical market to address vascular health issues. DiosVeinTM is made from the supplement diosmin, which has been used for over 30 years as an anti-inflammatory and vascular-protecting agent. DiosVeinTM is more frequently recommended by doctors in Europe for strengthening veins and aiding in circulation health than butcher's broom and horse chestnut. Derived from Sweet Orange, DiosVeinTM is rich in bioflavanoids and provides soothing relief of vein discomfort. Backed by clinical research, it is a popular treatment that has been recommended by doctors in Europe for over three decades.
Clinical studies conducted in Europe concluded that diosmin was an effective treatment of symptomatic capillary fragility and was efficacious in treating internal hemorrhoidal disease.
The first study published in International Angiology was a double-blind placebo controlled trial involving 100 patients (42 men and 58 women) over a six-week period to test if the veno-active flavonoid compound (in this case diosmin) could increase skin capillary resistance. At the end of the six-week period, there was significant improvement in the patient group taking diosmin. The conclusion was that at a daily dose of 1000mg, the diosmin significantly increased capillary resistance in patients with abnormal capillary fragility without significant side effects.
In the second study, published in Angiology The Journal of Vascular Disease, diosmin was compared to placebo in a double-blind trial to test the efficacy in the treatment of acute and chronic symptoms of hemorrhoids. The two-month trial consisting of 54 men and 66 women concluded that diosmin was a favorable treatment for hemorrhoids, and when used at the stages at which hemorrhoids are usually observed, did not interfere with other therapies.
A third study, also published in Angiology The Journal of Vascular Disease, concluded that diosmin, owing to its better bioavailability, its protective action on the walls of the venous compartment and its scarcity of side effects, can be considered a useful pharmacological agent in the treatments of hemorrhoids.
The DiosVeinTM brand of diosmin is now exclusively available through Berg Imports LLC. DiosVeinTM is developed and manufactured with the strictest processing standards to ensure safety and efficacy to its customers. For more information contact Cai Berg at 734-327-9723 or via email at [email protected].
# # #